Homburger advised CDR-Life on a new global licensing agreement with Boehringer Ingelheim, aimed at the development of an antibody-based molecule for autoimmune diseases. The context The agreement – which follows the companies’ collaboration on an investigational
Tags :Homburger
Homburger advised UBS Group on its issuance of USD 3.25 bn fixed rate/floating rate callable senior notes under its Senior Debt Programme. Governed by Swiss law, the notes have been provisionally admitted to trading on
Homburger advised Grant Thornton Advisors in connection with the company’s initiative to expand its multinational platform through the acquisitions of Grant Thornton Switzerland and Grant Thornton Liechtenstein. An investor group led by New Mountain
Homburger advised Siegfried Holding in connection with the company’s issuance of CHF 300 m 1.3% bonds, to be listed on the SIX Swiss Exchange. Zürcher Kantonalbank and Commerzbank Aktiengesellschaft served as managers on
Homburger advised Sonova Holding in connection with the company’s issuance of CHF 150 m bonds, listed on the SIX Swiss Exchange. Zürcher Kantonalbank and Deutsche Bank (Zurich Branch) served as managers on the
EQT, as part of a consortium of sellers, completed the sale of 8.4 % of Galderma’s share capital via an accelerated bookbuilding process. The consortium in question further includes Sunshine SwissCo, the Abu Dhabi Investment Authority (
Homburger advised Barnes Group as the company separated into two entities, Barnes Aerospace and The Industrial Solutions Group, each with its own leadership team and capital structure. The newborn companies Barnes Aerospace is a provider
Metall Zug accessed a new CHF 220 m syndicated, mortgage-backed revolving credit facility for the financing of investments in real estate developments on a former industrial site in Northern Zug, popularly known as Tech Cluster Zug.
Marex Group, a globally active financial services platform, completed the acquisition of Geneva-based fixed-income market maker Valcourt. In connection with the operation, Homburger advised the buyer, while Aegis represented the selling shareholders. The deal is
Homburger advised ADC Therapeutics , a commercial-stage biotechnology company with headquarters in Switzerland, on its USD 60 m private placement of common shares and pre-funded warrants. TCGX led the operation, with further participation from Redmile Group and
